As investors anxiously await tomorrow’s speech from the Federal Reserve Chair, the Fed rate cut threatens a recession.
Chief Investment Strategist Keith Fitz-Gerald answers investors’ questions on the current stock market climate, and giving two stock picks that are trading at fantastic prices…
See this video to get Keith’s insider opinion about what will happen next…
by Daniel Smoot
For the first time since 2007, the two-year and 10-year treasury yields have inverted.
But despite fears of a recession, tech stocks have a long history of outperforming the market during a yield-curve inversion.
With recession indicators flashing, investors are flocking to 10-year bonds that have the annual upside of just 1.5%.
But there are still market-beating stocks out there – in fact, one of our picks expects 103% growth.
And that brings us to the biotech industry.
There are some big biotech stocks to own right now that could deliver double, even triple-digit upside in less than 12 months.
When Amazon comes for a new industry, the legacy players quake in their boots.
And for good reason.
Here's what that means for real estate, and how you can take a cut of the gains...
The Dow Jones Industrial Average (DJIA) sank over 700 points in early August.
It was the market’s worst day of the year.
But that doesn’t mean all stocks are down. In fact, one of our best penny stocks to invest in right now could still bank you a 336% profit.
And we’re going to share our three top penny stocks with you...
The Dow Jones today will gain as the market prices in 100% odds of a September Fed rate cut.
Investors are preparing for a date with the Federal Reserve in Jackson Hole, Wyoming.
The U.S. central bank will kick off its annual seminar today.
Even casual investors have heard the name Jeffrey Gundlach; he's quoted nearly every week in financial publications.
Gundlach had dazzling success in the rough-and-tumble mortgage-backed securities and credit markets during a market that bankrupted his less savvy rivals. It was this success that led Barron's to acclaim him "King of Bonds" in a February 2011 cover story.
After just six months in the banking business, the ex-musician and summa cum laude Dartmouth philosophy and mathematics grad was managing several hundred million dollars – doing more than his bit to ensure Trust Company of the West Group spent the entire decade from 1999 to 2009 in the top 2% of intermediate-term bond funds.
When he left TCW in 2009, he founded his own firm, DoubleLine Capital. After barely eight months in business, DoubleLine outperformed every single one of the 91 other bond funds in the Morningstar intermediate-term bond category.
In other words, Gundlach has a legendary reputation – and a performance track record that more than backs it up.
And now… with the recommendation I'm about to share, the Bond King is coming to "work" for you!
And now... with the recommendation I'm about to share, the Bond King is coming to "work" for you!
As the political climate in Hong Kong reaches a boiling point, investors wonder how this will affect the U.S-China trade conflict.
Chief Investment Strategist Keith Fitz-Gerald has predicted what’s coming next as the trade war wages on.
To help our readers cash in on the explosive CBD market, we’re bringing you three of the top CBD stocks to invest in now.
You always hear that the market is “efficient,” but that’s just not the case.
In an “efficient market,” there are very few opportunities for outsized gains.
But you and I both know there are plenty of moneymaking opportunities in this market.
The best opportunities come from inefficiencies and overreactions.
Plunging bond yields have created huge opportunities for REITs. Today, we have a top REIT that pays 10%.
